Personalized medicine for pancreatic cancer: a step in the right direction
- PMID: 19041649
- DOI: 10.1053/j.gastro.2008.11.027
Personalized medicine for pancreatic cancer: a step in the right direction
Comment on
-
Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.Gastroenterology. 2009 Jan;136(1):187-95. doi: 10.1053/j.gastro.2008.09.067. Epub 2008 Oct 7. Gastroenterology. 2009. PMID: 18992248 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical